Both received Shodhana chikitsa by Virechana karma followed by Shamana chikitsa.The Virechana was given as a stat dose to both the patients at 11 a.m. of their respective days. They were advised to consume the combination over a period of 30–60 min to avoid aversion and regurgitation. Loose motions initiated 3–4 h after the ingestion and continued for 24 h and 19 h, respectively, ending with Kaphant Vierchana i.e. clear, colourless stool. After each loose motion, they were advised to consume at least 300 ml of water to avoid dehydration and to flush the intestines of the Pitta toxins.
DRUG PROFILE WITH POSOLOGY
Ghrit Pana for Virechana Panchatikta Ghrit was given for the purpose. This is a medicated Ghrit containing Nimba (Azadirachta indica), Patola (Luffa acutangula), Vyaghri (Solanum xanthocarpum), Guduchi (Tinospora cordifolia), Vasa (Adhatoda vasica). Abhayanga and Sarvanga Swedana preceded the Virechana procedure.
Ayurvedic Medicines: for Treatments:
Aragwadh (Cassia fistula) decoction
Ichcabhedi Ras having Croton tiglium
Kutki powder (Picrorrhiza kurroa)
Ghrit Pana: 20, 40, 60, 80, 100 ml on first 5 days
Rest on 6th day
Virechana 7th day after Abhayangam
Samsarjana diet; Khichri diet from 8th – 12th day
Shamana herbs: 13th day till 30 days
Both the patients were given Shaman Chikitsa with Manjistha, Nishoth and Haridra at the rate 2 g each, i.e., 6 g BD for 30 days after Virechana.
Both the patients showed complete compliance with the treatment. The patient A passed 32 loose stools while the patient B passed 28 stools before showing the desirable results of complete Virechana, i.e., colourless stools. Both the patients improved significantly after the said treatment. They did not require the regular antihistamines they were on for many years. If the conditions before and after the treatment were compared, both showed significant difference in itching, flares and discomfort. Even after a month of discontinuation of the oral herbal medication, they did not report recurrences.
Virechana is the best procedure against Pitta, the Dosha accountable for the symptoms of Shitapitta. Purgation induction could possibly take out the allergens from the gastrointestinal tract (GIT), reducing their concentration in blood and improving the symptoms. This happens due to the altered fluid dynamics and osmosis from the plasma into the alimentary tract [35-38. Most of the processes are temperature specific, and the intense purgation reducing the temperature in the small intestine could deactivate some of the allergens responsible for Urticaria. Once a great deal of toxins removed, Shaman herbs could ensure the nonrecurrence and the patients could be symptom free till date. Nishoth in the Shaman Chikitsa ensured mild everyday Virechana.
A troubling condition like Urticaria can be effectively controlled and cured with Panchakarma procedures. These being non chemical treatments, have all-round advantage over the conventional antihistamine approach. The results are fast to show and the patient need not continue the herbal treatment for long. In these two cases, Ayurveda cured Urticaria rather than treating or managing it.
1. Gogtay NJ, Bhatt HA, Dalvi SS, et al. The Use and Safety of Non-Allopathic Indian Medicines. Drug Safety. 2002; 25(14): 1005–19p.
2. Kashinatha S, Gorakhnatha C (Ed.). Charaka Samhita Sutrasthana 16/20, Part I. Varanasi, India: Chaukhambha Bharati Academy; 2006 (reprint). 321p. Tripathi
3. Tripathi, (Ed.). Yogaratnakarawith Vaidyaprabhahindi Commentary: Shitapitta Udarda Shittapitta Nidanam. Varanasi, India: Krishnadas Academy; 1998.
4. Shastri K, Chaturvedi GN (Eds.). Charaka Samhita Chikitsasthan-7/12 Reprint 2001. Varanasi, India: Choukhambha Bharati Academy; 2001. 182p.
5. Shastri K, Chaturvedi GN (Eds.). Charaka Samhita Chikitsasthan, 3/337 Reprint. 2001. Varanasi, India: Choukhambha Bharati Academy; 2001. 117p.
6. Shastri KN, Chaturvedi GN (Ed.). Charaka Samhita Nidanasthan, 1/24 Reprint-2001. Varanasi, India: Choukhambha Bharati Academy; 2001. 612p.
7. Shastri KN, Chaturvedi GN, (Ed.). Charaka Samhita Chikitsasthana 3/108 Reprint-2001. Varanasi, India: Choukhambha Bharati Academy; 2001. 85p.
8. Shastri KN, Chaturvedi GN (Ed.). Charaka Samhita Siddhisthana 1/ 16 Reprint-2001. Varanasi, India: Choukhambha Bharati Academy; 2001. 879p.
9. Shastri KA (Ed.). Maharshi Sushruta Virchitam Sushruta Samhita edited with ayurveda tattva sandipika; Sushruta Samhita Sutrasthana 42/12 reprinted on 2008. Varanasi, India: Choukhambha Bharati Academy; 2008. 157p.
10. Shastri KA (Ed.). Maharshi Sushruta Virchitam Sushruta Samhita edited with ayurveda tattva sandipika; Sushruta Samhita Kalpasthana 8/8; 15 reprinted on 2008. Varanasi, India: Choukhambha Bharati Academy; 2008. 64p.
11. Nirmala (Ed.).; hindi commentary Tripathi BN (Ed.). Shrimad Vagbhata Virchitam Ashtang Haridyam reprint 2007 Uttar Sthana 32/32-33. Varanasi, India: Chaukhamba Sanskrit Pratishthan; 2007. 1123p.
12. Upadhyaya YN (Ed.). Madhava Nidanam of Shri Madhavakara with the Madhukosha Sanskrit Commentry by Srivijayaksita and Srikanthadatta with the Vidyotini Hindi Commentary reprint 2007 50/1. Varanasi, India: Chaukhamba Sanskrit Pratishthan; 2007. 200p.
13. Shelley WB, Shelley ED. Adrenergic urticaria: a new form of stress-induced hives. Lancet. 1985; 2(8643): 1031–3p.
14. Upadhyaya Y (Ed.). Madhava Nidanam of Shri Madhavakara with the Madhukosha Sanskrit Commentry by Srivijayaksita and Srikanthadatta with the Vidyotini hindi commentary reprint 2007 49/2. Varanasi, India: Chaukhamba Sanskrit Pratishthan; 2007. 182p.
15. Upadhyaya YN (Ed.). Madhava Nidanam of Shri Madhavakara with the Madhukosha Sanskrit Commentry by Srivijayaksita and Srikanthadatta with the Vidyotini Hindi Commentary reprint 2007 50/4. Varanasi, India: Chaukhamba Sanskrit Pratishthan; 2007. 223p.
16. Cooper KD. Urticaria and angioedema: diagnosis and evaluation. J Am Acad Dermatol. 1991; 25: 166–74p.
17. Greaves MW. Chronic urticaria. N Engl J Med. 1995; 332: 1767–72p.
18. Ferrer M. Epidemiology, healthcare, resources, use and clinical features of different types of urticaria. J Investig Allergol Clin Immunol. 2009; 19(2): 21–6p.
19. Yadav S, Upadhyay A, Bajaj AK. Chronic Urticaria: An Overview. Ind J Dermatol. 2006; 51(3): 171–7p.
20. Humphreys F, Hunter JA. The characteristics of urticaria in 390 patients. Br J Dermatol. 1998; 138(4): 635–8p.
21. Herguner S, Kilic G, Karakoc S, et al. Levels of depression, anxiety and behavioural problems and frequency of psychiatric disorders in children with chronic idiopathic urticaria. Br J Dermatol. 2011; 164(6): 1342–7p.
22. DeLong LK, Culler SD, Saini SS, et al. Annual direct and indirect health care costs of chronic idiopathic urticaria:a cost analysis of 50 non-immuno suppressed patients. Arch Dermatol. 2008; 144: 35–9p.
23. Zuberbier T. Urticaria. Allergy. 2003; 58: 1224–34p.
24. Dauden E, Jimenez-Alonso I, Garcia-Diez A. Helicobacter pylori and idiopathic chronic urticaria. Int J Dermatol. 2000; 39: 446–52p.
25. Wedi B, Raap U, Kapp A. Chronic urticaria and infections. Curr Opin Allergy Clin Immunol. 2004; 4: 387–96p.
26. Giacometti A, Cirioni O, Antonicelli L, et al. Prevalence of intestinal parasites among individuals with allergic skin diseases. J Parasitol. 2003; 89: 490–2p.
27. Ronellenfitsch U, Bircher A, Hatz C, et al. Parasites as a cause of urticaria, Helminths and protozoa as triggers of hives? Hautarzt. 2007; 58: 133–41p.
28. Behl PN. Urticaria. In: Practice of Dermatology. Delhi, India: CBSE Publishers and Distributors; 1987. 121–2p.
29. Bossi F, Frossi B, Radillo O, et al. Mast cells are critically involved in serum- mediated vascular leakage in chronic urticaria beyond high affinity IgE receptor stimulation. Allergy. 2011; 66: 1538–45p.
30. Takahagi S, Tanaka T, Ishii K, et al. Sweat antigen induces histamine release from basophils of patients with cholinergic urticaria associated with atopic diathesis. Br J Dermatol. 2008; 160: 426–8p.
31. Zazzali JL, Broder MS, Chang E, et al. Cost, utilization, and patterns of medication use associated with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2012; 108: 98–102p.
32. Ferrer M, Luquin E, Kaplan AP. IL3 effect on basophils histamine release upon stimulation with chronic urticaria sera. Allergy. 2003; 58: 802–7p.
33. Wedi B, Novacovic V, Koerner M, et al. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression– inhibitory effects antiinflammatorydrugs. J Allergy Clin Immunol. 2000; 105: 552–60p.
34. Sabroe RA, Greaves MW. The pathogenesis of chronic idiopathic urticaria. Arch Dermatol. 1997; 133: 1003– 8p.
35. Popov TA. Challenges in the Management of Chronic Urticaria. World Allergy Organ J. 2011; 4(3): S28–S31.
36. Jáuregui I, Ferrer M, Montoro J, et all Antihistamines in the treatment of chronic urticaria. J Investig Allergol Clin Immunol. 2007; 17(2): 41–52p.
37. Chung-Jen C, Hsin-Su Y. Acupuncture Treatment of Urticaria. Arch Dermatol. 1998; 134: 1397–9p.
38. Chaturvedi A, Rao PN, Kumar MA, et al. Effect and Mechanism of Virechana Karma (Therapeutic Purgation) Over Fructose-Induced Metabolic Syndrome: An Experimental Study. J Evid Based Complementary Altern Med. 2016; 21(3): 194–201p.